Global Radiotherapy Market will be worth USD 8.1 billion by 2022 – New market reports by Data Bridge Market Research

“Global Radiotherapy Market is expected to grow at 7.1% in the forecast period 2016 to 2022”
Global Radiotherapy Market, By Therapy (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Global Radiotherapy Market is expected to reach USD 8.1 billion by 2022, from USD 4.9 billion in 2015 growing at a CAGR of 7.1% during the forecast period of 2016 to 2022.

Global Radiotherapy Market is segmented based on product types, therapy, application and geography.

For Sample Report: Global Radiotherapy Market – Trends and Forecast to 2022

Based on product type the market is segmented into EBRT equipment’s, and IBRT equipment’s. The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron). The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.

Based on therapy the market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy. On the basis of radiations delivered, the external beam radiotherapy is sub segmented into intensity-modulated radiation therapy (IMRT), image guided radiotherapy (IGRT), tomotherapy, stereotactic technology, 3D conformal radiotherapy, proton beam therapy, and volumetric modulated arc therapy (VMAT). The IGRT segment is expected to account for the largest share of the external beam radiotherapy market, whereas the VMAT segment is poised to witness the highest growth. Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR).

To read more about the scope and findings of this report visit: Global Radiotherapy Market, is expected to reach USD 8.1 billion by 2022

On the basis of indication the global radiotherapy market is segmented into brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.

Based on geography, the market report covers data for 5 regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.

Global players operating in this market are Varian Medical Systems, Inc., CIVCO Medical Solutions, Elekta AB, Nanobiotix, Accuray Incorporated, Brainlab AG, Ion Beam Applications SA, C. R. Bard, Inc., IsoRay Medical, Inc., TRF, Nordion, Inc., RaySearch Laboratories AB, PRECISIS AG, Mevion Medical Systems, Inc., and Mitsubishi Electric Corporation among other companies.

To Browse Full Report and Pricing: Global Radiotherapy Market – Trends and Forecast to 2022

 

Table of Content:

1        INTRODUCTION

        1.1.      OVERVIEW OF THE RADIOTHERAPY MARKET

        1.2.      MARKET SEGMENTATION & COVERAGE

                   1.2.1. CURRENCY AND PRICING 

                   1.2.2. LIMITATION

2        RESEARCH METHODOLOGY

        2.1.      KEY TAKEAWAYS

        2.2.      ARRIVING AT THE RADIOTHERAPY MARKET SIZE

                   2.2.1. MARKET CRACKDOWN APPROACH 

                   2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                   2.2.3. DATA TRIANGULATION

                   2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                   2.2.5.  KEY DATA POINTS FROM SECONDARY SOURCES

                   2.2.6.  PORTER’S FIVE FORCES MATRIX

                   2.2.7.  PEST ANALYSIS

                   2.2.8.  EPIDEMIOLOGY FORECASTING MODELS

        2.3.      GLOBAL RADIOTHERAPY MARKET: RESEARCH SNAPSHOT

        2.4.      ASSUMPTIONS

3        MARKET LANDSCAPE SUMMARY

4        PREMIUM INSIGHTS

        4.1.      OVERVIEW

        4.2.      RADIOTHERAPY MARKET: KEY PRIMARY INSIGHTS

        4.3.      MARKET OVERVIEW

                   4.3.1. DRIVERS 

                   4.3.2. RESTRAINTS

                   4.3.3. OPPURTUNITIES 

                   4.3.4. THREATS

        4.4.      KEY MARKET FINDINGS

        4.5.      KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5        RADIOTHERAPY MARKET, BY THERAPY TYPE

        5.1.      OVERVIEW

        5.2.      BEAM RADIOTHERAPY

                   5.2.1. IMAGE-GUIDED RADIOTHERAPY (IGRT)

                   5.2.2. INTENSITY MODULATED RADIOTHERAPY (IMRT)

                   5.3.3. VOLUMETRIC MODULATED ARC THERAPY (VMAT)

                   5.3.4. TOMOTHERAPY

                   5.3.5. STEREOTACTIC TECHNOLOGY

                   5.3.6. 3D CONFORMAL RADIOTHERAPY

        5.3.      BRACHYTHERAPY

                   5.2.1. LOW DOSE RATE (LDR)

                   5.2.2. HIGH DOSE RATE (HDR)

        5.4.      SYSTEMIC RADIOTHERAPY

6        RADIOTHERAPY MARKET, BY PRODUCT TYPE

        6.1.      OVERVIEW

        6.2.      EXTERNAL BEAM RADIOTHERAPY EQUIPMENT

                   6.2.1.      CYBERKNIFE

                   6.2.2.      GAMMAKNIFE

                   6.2.3.      LINAC

                   6.2.4.      PROTON BEAM

                                 6.2.4.1.      CYCLOTRON

                                 6.2.4.2.      SYNCLOTRON

        6.3.      INTERNAL RADIOTHERAPY PRODUCTS

                   6.3.1.      SEEDS

                   6.3.2.      AFTERLOADERS

                   6.3.3.      OTHERS

        6.4.      RADIOTHERAPY SOFTWARES

                   6.4.1.      TREATMENT PLANNING SOFTWARES

                   6.4.2.      DOSAGE PLANNING SOFTWARES

                   6.4.3.      PATEINT POSITIONING SOFTWARES

                   6.4.4.      IMAGE GUIDING SOFTWARES

        6.5.      SYSTEMIC RADIOTHERAPY

7        RADIOTHERAPY MARKET, BY INDICATION

        7.1.      OVERVIEW

        7.2.      BRAIN TUMOR

        7.3.      SPINE CANCER

        7.4.      LUNG CANCER

        7.5.      LIVER CANCER

        7.6.      BREAST TUMOR

        7.7.      PROSTRATE CANCER

        7.8.      OTHERS

8        PATIENT VOLUME, BY INDICATION

        8.1.      OVERVIEW

        8.2.      BRAIN TUMOR

        8.3.      SPINE CANCER

        8.4.      LUNG CANCER

        8.5.      LIVER CANCER

        8.6.      BREAST TUMOR

        8.7.      PROSTRATE CANCER

9          RADIOTHERAPY MARKET, BY END USER

         9.1.      OVERVIEW

         9.2.      HOSPITALS

         9.3.      CANCER INSTITUTES

         9.4.      ONCOLOGY CLINICS

10      RADIOTHERAPY MARKET, BY GEOGRAPHY

        10.1.   COUNTRYWISE RADIOTHERAPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS                        CHAPTER BY COUNTRY)

                 10.1.1.      NORTH AMERICA

                                10.1.1.1.      U.S.

                                10.1.1.2.      CANADA

                                10.1.1.3.      MEXICO

                 10.1.2.      EUROPE

                                10.1.2.1.      GERMANY

                                10.1.2.2.      FRANCE

                                10.1.2.3.      U.K.

                                10.1.2.4.      ITALY

                                10.1.2.5.      SPAIN

                                10.1.2.6.      RUSSIA

                                10.1.2.7.      TURKEY

                                10.1.2.8.      BELGIUM

                                10.1.2.9.      NETHERLANDS

                                10.1.2.10.    SWITZERLAND

                                10.1.2.11.    REST OF EUROPE

                 10.1.3.      ASIA-PACIFIC (APAC)

                                10.1.3.1.      JAPAN

                                10.1.3.2.      CHINA

                                10.1.3.3.      SOUTH KOREA

                                10.1.3.4.      INDIA

                                10.1.3.5.      AUSTRALIA

                                10.1.3.6.      SINGAPORE

                                10.1.3.7.      THAILAND

                                10.1.3.8.      MALAYSIA

                                10.1.3.9.      REST OF APAC

                 10.1.4.    LATIN AMERICA

                              10.1.4.1.     BRAZIL

                              10.1.4.2.     REST OF LATIN AMERICA

                 10.1.5.    MIDDLE EAST AND AFRICA

                              10.1.5.1.     SOUTH AFRICA

                              10.1.5.2.     REST OF MIDDLE EAST AND AFRICA

        10.2.   KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11      RADIOTHERAPY MARKET: COMPETITIVE LANDSCAPE

        11.1.   GLOBAL RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS

        11.2.   NORTH AMERICA RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS

        11.3.   EUROPE RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS

        11.4.   APAC RADIOTHERAPY MARKET: COMPANY SHARE ANALYSIS

        11.5.   MERGERS & ACQUISITIONS

        11.6.   NEW PRODUCT DEVELOPMENT & APPROVALS

        11.7.   EXPANSIONS

        11.8.   REGULATORY CHANGES

        11.9.   PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12      RADIOTHERAPY MARKET, COMPANY PROFILES

        12.1    VARIAN MEDICAL SYSTEMS, INC.

                  12.1.1   OVERVIEW

                  12.1.2   SWOT ANALYSIS

                  12.1.3   PRODUCT PORTFOLIO

                  12.1.4   REVENUE ANALYSIS

                  12.1.5   ANALYSTS VIEW

        12.2    CIVCO MEDICAL SOLUTIONS

                  12.2.1   OVERVIEW

                  12.2.2   SWOT ANALYSIS

                  12.2.3   PRODUCT PORTFOLIO

                  12.2.4   REVENUE ANALYSIS

                  12.2.5   ANALYSTS VIEW

        12.3    ELEKTA AB

                  12.3.1   OVERVIEW

                  12.3.2   SWOT ANALYSIS

                  12.3.3   PRODUCT PORTFOLIO

                  12.3.4   REVENUE ANALYSIS

                  12.3.5   ANALYST VIEW

        12.4    NANOBIOTIX

                  12.4.1   OVERVIEW

                  12.4.2   SWOT ANALYSIS

                  12.4.3   PRODUCT PORTFOLIO

                  12.4.4   REVENUE ANALYSIS

                  12.4.5   ANALYSTS VIEW

        12.5    ACCURAY INCORPORATED

                  12.5.1   OVERVIEW

                  12.5.2   SWOT ANALYSIS

                  12.5.3   PRODUCT PORTFOLIO

                  12.5.4   REVENUE ANALYSIS

                  12.5.5   ANALYSTS VIEW

        12.6    BRAINLAB AG

                  12.6.1   OVERVIEW

                  12.6.2   SWOT ANALYSIS

                  12.6.3   PRODUCT PORTFOLIO

                  12.6.4   REVENUE ANALYSIS

                  12.6.5   ANALYSTS VIEW

        12.7    ION BEAM APPLICATIONS SA

                  12.7.1   OVERVIEW

                  12.7.2   SWOT ANALYSIS

                  12.7.3   PRODUCT PORTFOLIO

                  12.7.4   REVENUE ANALYSIS

                  12.7.5   ANALYSTS VIEW

        12.8    C. R. BARD, INC.

                  12.8.1   OVERVIEW

                  12.8.2   SWOT ANALYSIS

                  12.8.3   PRODUCT PORTFOLIO

                  12.8.4   REVENUE ANALYSIS

                  12.8.5   ANALYSTS VIEW

        12.9    ISORAY MEDICAL, INC.

                  12.9.1   OVERVIEW

                  12.9.2   SWOT ANALYSIS

                  12.9.3   PRODUCT PORTFOLIO

                  12.9.4   REVENUE ANALYSIS

                  12.9.5   ANALYSTS VIEW

        12.10  TRF

                 12.10.1   OVERVIEW

                 12.10.2   SWOT ANALYSIS

                 12.10.3   PRODUCT PORTFOLIO

                 12.10.4   REVENUE ANALYSIS

                 12.10.5   ANALYSTS VIEW

        12.11  NORDION, INC.

                 12.11.1   OVERVIEW

                 12.11.2   SWOT ANALYSIS

                 12.11.3   PRODUCT PORTFOLIO

                 12.11.4   REVENUE ANALYSIS

                 12.11.5   ANALYSTS VIEW

        12.12  RAYSEARCH LABORATORIES AB

                 12.12.1   OVERVIEW

                 12.12.2   SWOT ANALYSIS

                 12.12.3   PRODUCT PORTFOLIO

                 12.12.4   REVENUE ANALYSIS

                 12.12.5   ANALYSTS VIEW

        12.13  PRECISIS AG

                 12.13.1   OVERVIEW

                 12.13.2   SWOT ANALYSIS

                 12.13.3   PRODUCT PORTFOLIO

                 12.13.4   REVENUE ANALYSIS

                 12.13.5   ANALYSTS VIEW

        12.14  MEVION MEDICAL SYSTEMS, INC.

                 12.14.1   OVERVIEW

                 12.14.2   SWOT ANALYSIS

                 12.14.3   PRODUCT PORTFOLIO

                 12.14.4   REVENUE ANALYSIS

                 12.14.5   ANALYSTS VIEW

        12.12  MITSUBISHI ELECTRIC CORPORATION

                 12.12.1   OVERVIEW

                 12.12.2   SWOT ANALYSIS

                 12.12.3   PRODUCT PORTFOLIO

                 12.12.4   REVENUE ANALYSIS

                 12.12.5   ANALYSTS VIEW

13      APPENDIX

        13.1    RELATED REPORTS

        13.2    CUSTOMIZABLE OPTIONS

        13.3    SOURCE SHEET

        13.4    BIBLIOGRAPHY

14      ABOUT DATA BRIDGE MARKET RESEARCH

 

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Cord Stem Cell Banking Market – Trends and Forecast to 2022

By Storage Type (Private Banking, Public Banking), By Product Type (Cord Blood, Cord Blood & Cord Tissue), By Service Type (Collection & Transportation, Processing, Analysis, Storage), By Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), By Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2022

Global Drug Delivery Devices Market – Trends and Forecast to 2022

By Product Type (Oral (Solid, Liquid,Semi-Solid), Injectable (Devices (Conventional, Self-Injectable), Formulations), Topical (Transdermal Devices (Patches, Gels), Formulations), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Healthcare, Others), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-radiotherapy-market/